Details for New Drug Application (NDA): 218061
✉ Email this page to a colleague
The generic ingredient in CETRORELIX ACETATE is cetrorelix acetate. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the cetrorelix acetate profile page.
Summary for 218061
| Tradename: | CETRORELIX ACETATE |
| Applicant: | Xiromed |
| Ingredient: | cetrorelix acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;SUBCUTANEOUS | Strength | EQ 0.25MG BASE/VIAL | ||||
| Approval Date: | Jun 3, 2025 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
